Health Care

Complaint filed over ketamine research without prior consent

A consumer rights group has filed a complaint alleging a Minneapolis health care provider ignored ethical practices and federal safeguards when it researched the effect of the powerful sedative ketamine on more than 100 participants without their prior consent.

Drug maker GSK invests in gene profiling services

Drug maker GlaxoSmithKline says second-quarter revenue was 7.3 billion pounds ($9.6 billion), up 4 percent when discounting currency shifts, amid a promising performance of a new shingles treatment.

Lilly: 2Q Earnings Snapshot

Eli Lilly and Co. (LLY) on Tuesday reported a second-quarter loss of $259.9 million, after reporting a profit in the same period a year earlier.